Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Issa

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Clinical Immunology (Orlando, Fla.)|October 31, 2003
Age-related epigenetic changes and the immune systemJean-Pierre Issa
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
DNA methylation in the treatment of hematologic malignanciesJean-Pierre Issa
The Journal of Clinical Investigation|January 3, 2014
Aging and epigenetic drift: a vicious cycleJean-Pierre Issa
The Journal of Nutrition|August 7, 2002
Epigenetic variation and human diseaseJean-Pierre Issa
Nature Genetics|July 28, 2011
Epigenetic variation and cellular DarwinismJean-Pierre Issa
Nature Clinical Practice. Oncology|December 13, 2005
Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: dose, duration, and patient selectionJean-Pierre Issa
Nature Reviews. Cancer|December 2, 2004
CpG island methylator phenotype in cancerJean-Pierre Issa
Current Opinion in Oncology|November 19, 2003
DecitabineJean-Pierre Issa
Cancer Research|April 4, 2022
The Two-Hit Hypothesis Meets EpigeneticsJean-Pierre Issa
Hematology/Oncology Clinics of North America|April 3, 2010
Epigenetic changes in the myelodysplastic syndromeJean-Pierre Issa
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Clinical Immunology (Orlando, Fla.)|October 31, 2003
Age-related epigenetic changes and the immune systemJean-Pierre Issa
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
DNA methylation in the treatment of hematologic malignanciesJean-Pierre Issa
The Journal of Clinical Investigation|January 3, 2014
Aging and epigenetic drift: a vicious cycleJean-Pierre Issa
The Journal of Nutrition|August 7, 2002
Epigenetic variation and human diseaseJean-Pierre Issa
Nature Genetics|July 28, 2011
Epigenetic variation and cellular DarwinismJean-Pierre Issa
Nature Clinical Practice. Oncology|December 13, 2005
Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: dose, duration, and patient selectionJean-Pierre Issa
Nature Reviews. Cancer|December 2, 2004
CpG island methylator phenotype in cancerJean-Pierre Issa
Current Opinion in Oncology|November 19, 2003
DecitabineJean-Pierre Issa
Cancer Research|April 4, 2022
The Two-Hit Hypothesis Meets EpigeneticsJean-Pierre Issa
Hematology/Oncology Clinics of North America|April 3, 2010
Epigenetic changes in the myelodysplastic syndromeJean-Pierre Issa
Pageof 10